Skip to content

The Archive · A Source

Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland

PMC 2025 www.ncbi.nlm.nih.gov/pmc/articles/PMC12226472